NRAS and BRAF mutations in atypical melanocytic lesions arising in melanoma patients treated with vemurafenib

被引：0
|
作者：
Chu, Emily Y.
Wilson, Melissa
Sobanko, Joseph
Miller, Christopher
Suh, EunRan
Xu, Wei
Letrero, Richard
Elenitsas, Rosalie
Karakousis, Giorgos
Xu, Xiao Wei
Elder, David
Amaravadi, Ravi K.
Schuchter, Lynn Mara
Nathanson, Katherine L.
机构：
[1] Hosp Univ Penn, Philadelphia, PA 19104 USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9017
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Melanoma Effectiveness of Vemurafenib on BRAF V600 Mutations
    Voos, Dunja
    AKTUELLE DERMATOLOGIE, 2014, 40 (11) : 434 - 434
  • [32] Mutations of the BRAF gene in benign and malignant melanocytic lesions
    Yazdi, AS
    Palmedo, G
    Flaig, MJ
    Puchta, U
    Reckwerth, A
    Rütten, A
    Mentzel, T
    Hügel, H
    Hantschke, M
    Schmid-Wendtner, MH
    Kutzner, H
    Sander, CA
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (05) : 1160 - 1162
  • [33] Co-occurrence of NRAS and BRAF activating mutations in congenital melanocytic naevi
    Polubothu, S.
    Chalker, J.
    Kinsler, V.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 : 78 - 78
  • [34] BRAF and NRAS Mutations are Heterogeneous and Not Mutually Exclusive in Nodular Melanoma
    Chiappetta, Caterina
    Proietti, Ilaria
    Soccodato, Valentina
    Puggioni, Chiara
    Zaralli, Roberto
    Pacini, Luca
    Porta, Natale
    Skroza, Nevena
    Petrozza, Vincenzo
    Potenza, Concetta
    Della Rocca, Carlo
    Di Cristofano, Claudio
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2015, 23 (03) : 172 - 177
  • [35] Somatic BRAF and NRAS mutations in familial melanoma: a GenoMEL study
    Zebary, Abdlsattar
    Omholt, Katarina
    van Nieuwpoort, Frans A.
    Ghiorzo, Paola
    Gruis, Nelleka A.
    Harbst, Katja
    Hayward, Nicholas K.
    Jonsson, Goran B.
    Pjanova, Dace
    Puig, Susana
    Scarra, Giovanna B.
    Whitaker, Linda M.
    Newton-Bishop, Julia
    Hansson, Johan
    CANCER RESEARCH, 2011, 71
  • [36] Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma
    Goel, Vikas K.
    Lazar, Alexander J. F.
    Warneke, Carla L.
    Redston, Mark S.
    Haluska, Frank G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (01) : 154 - 160
  • [37] Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma
    Ellerhorst, Julie A.
    Greene, Victoria R.
    Ekmekcioglu, Suhendan
    Warneke, Carla L.
    Johnson, Marcella M.
    Cooke, Carolyn P.
    Wang, Li-E
    Prieto, Victor G.
    Gershenwald, Jeffrey E.
    Wei, Qingyi
    Grimm, Elizabeth A.
    CLINICAL CANCER RESEARCH, 2011, 17 (02) : 229 - 235
  • [38] BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs
    Wong, CW
    Fan, YS
    Chan, TL
    Chan, ASW
    Ho, LC
    Ma, TKF
    Yuen, ST
    Leung, SY
    JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (06) : 640 - 644
  • [39] Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma
    Moltara, Maja Ebert
    Novakovic, Srdjan
    Boc, Marko
    Bucic, Marina
    Rebersek, Martina
    Zadnik, Vesna
    Ocvirk, Janja
    RADIOLOGY AND ONCOLOGY, 2018, 52 (03) : 289 - 295
  • [40] KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma
    Zebary, Abdlsattar
    Omholt, Katarina
    Vassilaki, Ismini
    Hoiom, Veronica
    Linden, Diana
    Viberg, Lisa
    Kanter-Lewensohn, Lena
    Johansson, Carolina Hertzman
    Hansson, Johan
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2013, 72 (03) : 284 - 289
12345